川瀬 孝和

Medicine & Life Sciences

1. Graft vs Host Disease 100%
2. Unrelated Donors 74%
3. Bone Marrow Transplantation 72%
4. HLA Antigens 63%
5. Confidence Intervals 58%
6. Japan 56%
7. Tissue Donors 54%
8. Alleles 48%
9. Minor Histocompatibility Antigens 47%
10. Bone Marrow 39%
11. Hematopoietic Stem Cell Transplantation 38%
12. Odds Ratio 37%
13. Transplants 36%
14. Haplotypes 35%
15. Fetal Blood 34%
16. Case-Control Studies 34%
17. Cell Transplantation 33%
18. Alcohol Drinking 31%
19. Single Nucleotide Polymorphism 31%
20. Transplantation 31%
21. Allogeneic Cells 30%
22. Genes 30%
23. Genotype 29%
24. Neoplasms 29%
25. Breast Neoplasms 27%
26. Adult T Cell Leukemia Lymphoma 27%
27. Population 26%
28. Aldehyde Dehydrogenase 23%
29. Alcohols 23%
30. Multiple Myeloma 19%
31. Recurrence 19%
32. Leukemia 19%
33. T-Lymphocytes 18%
34. Logistic Models 18%
35. Survival 18%
36. Homologous Transplantation 18%
37. Cyclophosphamide 18%
38. Stomach Neoplasms 18%
39. Genetic Polymorphisms 17%
40. Alcohol Dehydrogenase 17%
41. Drug Therapy 17%
42. Aplastic Anaemia 16%
43. Mortality 16%
44. Stem Cell Transplantation 16%
45. Endometrial Neoplasms 15%
46. Interleukin-17 15%
47. Hematologic Neoplasms 15%
48. Life Style 14%
49. Enzymes 13%
50. Cytomegalovirus 13%